QureshiAITuhrimSBroderickJBatjerHHondoHHanleyD.
Spontaneous intracerebral haemorrhage. N Engl J
Med2001; 344:
1450–60.
2.
MayerSBrunNBegtrupK. Efficacy and safety of recombinant activated
factor VII for acute intracerebral hemorrhage. N Engl J
Med2008;
358:2127–37.
3.
AndersonCSHuangYWangJG. Intensive blood pressure reduction in acute
cerebral haemorrhage trial (INTERACT): a randomised pilot trial.
Lancet Neurol2008;
7:391–9.
4.
Arima H, Anderson CS, Wang
JG et al. for the INTERACT investigators. Lower
treatment blood pressure is associated with greatest reduction in hematoma growth after
acute intracerebral hemorrhage. Hypertension2010;
56:852–8.
5.
Arima H, Huang Y, Wang JG
et al. for the INTERACT1 Investigators. Earlier
blood pressure-lowering and greater attenuation of hematoma growth in acute
intracerebral hemorrhage: INTERACT pilot phase. Stroke2012;
43:2236–8.
6.
Delcourt C, Huang Y, Wang J
et al. for the INTERACT2 Investigators. The
second (main) phase of an open, randomised, multicentre study to investigate the
effectiveness of an INTEnsive blood pressure Reduction in Acute Cerebral haemorrhage
Trial (INTERACT2). Int J Stroke2010;
5:110–6.
7.
Delcourt C, Huang Y, Arima
H et al. for the INTERACT1 Investigators.
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1
study. Neurology2012;
79:314–9.
8.
DavisSHennericiMBrunNDiringerMMayerSBegtrupM.
Hematoma growth is a determinant of mortality and poor outcome after
intracerebral hemorrhage. Neurology2006;
66:1175–81.
